Optimal Surgical Timing after Neoadjuvant Therapy for Stage IIIa Non-Small Cell Lung Cancer.

CONCLUSIONS: The delay in surgical resection of StageIIIa NSCLC is not associated increased early mortality, however it is associated with worse 3-year post-resection survival. PMID: 31756320 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31756320?dopt=Abstract

Source: The Annals of Thoracic Surgery - November 18, 2019 Category: Cardiovascular & Thoracic Surgery Authors: Rice JD, Heidel J, Trivedi JR, van Berkel VH Tags: Ann Thorac Surg Source Type: research